Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05519683 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Home Transcutaneous Electrical Acustimulation (TEA)

Study acronym: Home-TEA
StatusRecruiting
PhasePhase 2/3
Started2022-11-02
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Sep 2026 → Mar 2027
See other at-risk trials from University of Michigan

Amendment history

2026-09-18
Primary completion pushed: 2026-09 → 2027-03
Completion pushed: 2026-09 → 2027-03
2025-10-09
Study Status v5
Primary completion date2025-09→2026-09
Completion date2025-09→2026-09
2025-01-07
2 amendments v3-v4
2 re-verifications since 2024-01-07, no change to tracked fields
2022-12-02
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-11→confirmed 2022-11-02
Study sitesdetails revised at 1 of 1 site
2022-11-07
Study Status v1
Start date2022-09→2022-11
2022-08-24
Original filing
This study will assess the efficacy of two active treatments with TEA and a chemical neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on abdominal pain.
Trial Details
NCT Number NCT05519683
Lead Sponsor University of Michigan
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), National Center for Complementary and Integrative Health (NCCIH)
Conditions Irritable Bowel Syndrome With Constipation
Enrollment 160 participants
Start Date 2022-11-02
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-09-17